TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 46 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $3,170,000 | -68.6% | 1,315,551 | 0.0% | 0.14% | -67.0% |
Q4 2015 | $10,090,000 | +45.0% | 1,315,551 | 0.0% | 0.41% | +52.0% |
Q3 2015 | $6,959,000 | -41.0% | 1,315,551 | 0.0% | 0.27% | -31.6% |
Q2 2015 | $11,800,000 | +36.8% | 1,315,551 | -3.6% | 0.39% | +40.9% |
Q1 2015 | $8,627,000 | +239.0% | 1,365,000 | +458.2% | 0.28% | +168.3% |
Q1 2014 | $2,545,000 | – | 244,524 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 392,952 | $4,051,000 | 0.53% |
BLUESTEIN R H & CO LLC | 179,800 | $1,854,000 | 0.12% |
Edge Wealth Management LLC | 15,000 | $154,000 | 0.07% |
Tower Research Capital LLC (TRC) | 1,316 | $14,000 | 0.00% |
VANGUARD GROUP INC | 37,190 | $384,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 100 | $1,000 | 0.00% |
UBS AG | 1,878 | $19,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 106 | $1,000 | 0.00% |
FIRST MANHATTAN CO. LLC. | 2,500 | $25,000 | 0.00% |
CREDIT SUISSE AG/ | 19,370 | $200,000 | 0.00% |